Early Access — free while we kick the tires
EdgarHawk

Jalazo April

10% Owner

10% Owner
5 filings analyzed · 1 company · Latest 2025-02-18

Companies

Company Buys Sells Direction
Zurn Elkay Water Solutions Corp ZWS 0 6 Net selling

Activity

February 2025
Sell
8,912,500 shares
$299,460,000
Significance 6/10

Jalazo April sold 8,912,500 shares (8.91M) of ZWS at $33.60 for $299,460,000; reduces holdings by 37.3% to 15.00M shares

Jalazo April executed a substantial divestiture of 8,912,500 shares, cutting his ZWS position by 37.3% and reducing post-transaction holdings to 15,002,819 shares. At $33.60 per share, the transaction values the sale at $299,460,000. The sale occurs as ZWS trades 12.5% below its 52-week high of $40.92, and the stock has declined 6.3% over the prior 30 days and 7.8% over the prior 90 days. Examining his prior sales at this ticker specifically: of his 5 prior ZWS sales, only 1 of 5 was well-timed at the 90-day mark (20% well-timed rate), and his cross-ticker track record shows a 73.33% well-timed sell rate with an average 90-day return of +0.2% after his sales—indicating his past sales have not consistently preceded declines. The company's fundamentals show P/E of 32.83, annual revenue growth of +2.4%, and net income of $43,500,000 on quarterly revenue of $410,000,000, neither revealing obvious distress nor obvious strength. The magnitude and visibility of this near-$300M sale, reducing an already-concentrated position, is material and merits investor attention.

July 2024
medium
Sell
111,760 shares
$3,248,863
Significance 6/10

10% owner Jalazo April sold 111,760 shares of ZWS at $29.07 on 2024-07-02 for $3.2M; stock now down 13.1% from 52-week high.

Jalazo April, a 10% owner, sold 111,760 shares at $29.07, reducing his stake from 23.57M to 23.45M shares—a modest -0.5% reduction despite the sale size. The transaction occurred when ZWS stock was already -13.1% from its 52-week high and -5.8% over the prior 30 days, but these price-action markers alone do not indicate insider motivation. More notably, Jalazo's cross-ticker track record shows a 100.00% well-timed rate on 14 prior sells with an average 90d return of -8.1%, suggesting a strong pattern of selling ahead of declines. However, at ZWS specifically, his 5 prior trades show no measurable well-timed outcomes at the 90-day mark—0 of 0 prior sells achieved negative 90d returns. The June cluster of four sells (June 10, 12, 20, 28) followed by this July 2 sale suggests sustained disposition activity, though outcomes on those earlier trades remain unmeasurable. With ZWS trading at a 40.39 P/E and posting +19.4% annual revenue growth, the company's fundamentals do not indicate distress, making this a case of repeated sales by a large shareholder rather than a distressed exit.

medium
Sell
100,000 shares
$2,904,000
Significance 5/10

10% owner Jalazo April sold 100,000 shares (100.0K shares) of ZWS at $29.04 on 2024-06-28, total value $2,904,000.00 ($2.9M)

Jalazo April, a 10% owner of Zurn Elkay Water Solutions, sold 100,000 shares at $29.04 on 2024-06-28, representing a modest -0.4% reduction of holdings to 23.57M shares. The stock has declined -12.8% from its 52-week high of $33.47 and -6.8% in the 30 days following the sale. His prior five trades at ZWS have all been sales occurring within a 43-day window (2024-05-24 through 2024-07-02), establishing a consistent pattern of liquidation at this ticker. Across his broader cross-ticker track record of 14 prior sells, his average 30-day return was -0.7%, though none of his prior same-ticker sales have yet produced measurable 90-day outcomes. The company's recent quarterly revenue is $373.8M with net income of $34.3M, though the current P/E of 40.53 remains elevated relative to the stock's recent price weakness.

June 2024
medium
Sell
36,938 shares
$1,124,393
Significance 4/10

10% Owner Jalazo April sold 36,938 shares of ZWS at $30.44 on 2024-06-20 (1.1M), retaining 23.68M shares.

Jalazo April, a 10% owner, sold 36,938 shares at $30.44 on 2024-06-20 for $1,124,392.72 as part of a series of six sales within a month (also selling on 2024-06-12, 2024-06-10, 2024-05-24, 2024-05-22, and 2024-04-23), while retaining substantial stakes of 23.68M shares post-transaction. The stock has declined 10.1% from its 52-week high of $33.47 and currently trades at $30.10, down 5.8% over 30 days and 6.8% over 90 days. His prior sales at ZWS have shown negative 30-day returns (ranging from -2.2% to -7.5% where measurable), though the 90-day outcomes for recent transactions remain incomplete. ZWS fundamentals show strong growth (revenue up 19.4% year-over-year to $373.8M and net income of $34.3M in the latest quarter) and a high P/E of 41.81 despite a $5.2B market cap. The repeated disposition pattern warrants monitoring as it coincides with stock price weakness and multiples remain elevated.

medium
Sell
194,081 shares
$6,123,256
Significance 5/10

10% Owner Jalazo April sold 194,081 shares of ZWS at $31.55 on 2024-06-12; stock now $30.62, down 6.6% in 30 days

Jalazo April, a 10% owner of Zurn Elkay Water Solutions, sold 194,081 shares at $31.55 on 2024-06-12 for a total of $6,123,255.55. The stock has declined to $30.62 (currently -8.5% from the 52-week high of $33.47) and down 6.6% over the past 30 days. This is the insider's third consecutive sale within five days (June 10, June 12 being the filing subject), part of a broader pattern of selling activity at ZWS: five prior trades in this ticker were all sales, with measurable outcomes showing mixed timing (one sale had a +0.6% 30-day return, another -2.2%). The company's fundamentals show revenue of $373,800,000.00 and net income of $34,300,000.00 in the latest quarter, with strong annual revenue growth of +19.4%, though the P/E of 42.53 reflects a premium valuation. The timing of multiple consecutive sales by a 10% owner warrants attention, even as recent price weakness and elevated valuation multiples provide context for the trading activity.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access